OSLER
LIVE

Serial Number

79432124

Owner

Osler Diagnostics Limited

Attorney

Eric Lamb

Filing Date

Jul 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OSLER Trademark

Serial Number: 79432124

OSLER is a trademark filed by Osler Diagnostics Limited on July 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Osler Diagnostics Limited (12 trademarks)

King Charles House,

Entity Type: 99

Trademark Details

Filing Date

July 28, 2025

Registration Date

Not Registered

Goods & Services

Medical services; medical diagnostic services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and information services relating to or connected with the aforementioned services.

medical preparations, namely, diagnostic reagents for in vitro use in haematology, biochemistry, clinical chemistry and microbiology for medical purposes; chemical preparations, namely, diagnostic assays and reagents for diagnostic testing for medical purposes; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for the testing of blood, body fluids, blood derivatives and body fluid derivatives.

Scientific apparatus and instruments, namely, analysers and cartridges for laboratory use for testing chemical, biological and environmental samples for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, analysers and cartridges for laboratory use for haematology, biochemistry, clinical chemistry and microbiology testing; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for the analysis of blood, body fluids, blood derivatives and body fluid derivatives for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; scientific research and laboratory apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in liquid samples, blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; scientific research and laboratory apparatus and instruments, namely, blood testing apparatus for scientific or clinical research purposes; scientific research and laboratory apparatus and instruments, namely, apparatus for blood analysis for scientific or clinical research purposes; material testing apparatus and instruments, namely, diagnostic testing apparatus and instruments for the detection and measurement of clinical biomarkers in blood and bodily fluids for scientific or clinical research use; monitoring, measuring, signalling and control apparatus and instruments, namely, signal measuring instruments for use in electrochemical analysis, potentiostats, galvanostats and impedance analysers; computer apparatus and instruments, namely, computer hardware and peripheral apparatus for clinical research or scientific purposes; downloadable software for analysing data obtained from blood, body fluids, blood derivatives and body fluid derivatives and downloadable software for operating analytical and diagnostic devices; downloadable application software for management of patient data, healthcare workflow and connectivity between patients and healthcare providers; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; structural parts and fittings for all the aforementioned goods.

Assays and reagents for scientific or medical research purposes.

Medical apparatus and instruments, namely, analysers and cartridges for haematology, biochemistry, clinical chemistry and microbiology testing; medical apparatus and instruments, namely, diagnostic devices for the analysis of blood, body fluids, blood derivatives and body fluid derivatives; medical apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical apparatus and instruments, namely, wearable devices with sensors for monitoring patient vital signs, blood and sweat properties and physical movement; medical diagnostic apparatus and instruments, namely, diagnostic devices for detecting and measuring pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical diagnostic apparatus and instruments, namely, analysers and cartridges for use in diagnosing and monitoring acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; blood testing apparatus and instruments for medical and medical diagnostic purposes, namely, electrochemical biosensors for the determination of concentrations of target analytes in body fluids for medical purposes; testing apparatus and instruments for medical and medical diagnostic purposes, namely, electronic measuring instruments for medical use for the analysis of samples of blood, body fluids, blood derivatives and body fluid derivatives; medical diagnostic testing apparatus and instruments for the measurement of clinical bio markers; structural parts and fittings for all the aforementioned goods.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2026 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 28, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 28, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 28, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 28, 2026 COAR
REFUSAL PROCESSED BY IB
Feb 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 19, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 19, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 4, 2025 SDRC